(Q39519018)

English

Efficacy of Topical Liposomal Amphotericin B versus Intralesional Meglumine Antimoniate (Glucantime) in the Treatment of Cutaneous Leishmaniasis

scientific article published on 24 November 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

Efficacy of Topical Liposomal Amphotericin B versus Intralesional Meglumine Antimoniate (Glucantime) in the Treatment of Cutaneous Leishmaniasis (English)

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

1 reference

based on heuristic

inferred from title

meglumine antimoniate

1 reference

based on heuristic

inferred from title

author name string

Pouran Layegh

1

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

Omid Rajabi

2

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

Mahmoud Reza Jafari

3

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

Parisa Emamgholi Tabar Malekshah

4

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

Toktam Moghiman

5

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

Hami Ashraf

6

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

Roshanak Salari

7

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

24 November 2011

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

Journal of Parasitology Research

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

2011

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

656523

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

copyright license

Creative Commons Attribution 3.0 Unported

1 January 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

0 references

Systemic meglumine antimoniate in acute cutaneous leishmaniasis: children versus adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228299

12 September 2017

Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228299

12 September 2017

Production and characterization of stable amphotericin-resistant amastigotes and promastigotes of Leishmania mexicana.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228299

12 September 2017

Successful liposomal amphotericin B treatment of Leishmania braziliensis cutaneous leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228299

12 September 2017

Chemotherapy of leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228299

12 September 2017

Amphotericin B preparations: a maximum tolerated dose in severe invasive fungal infections?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228299

12 September 2017

Cutaneous leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228299

12 September 2017

Efficacious topical treatment for murine cutaneous leishmaniasis with ethanolic formulations of amphotericin B.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228299

12 September 2017

Low-dose liposomal amphotericin B in refractory Indian visceral leishmaniasis: a multicenter study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228299

14 September 2017

Evaluation of PCR assay in diagnosis and identification of cutaneous leishmaniasis: a comparison with the parasitological methods.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228299

21 August 2018

Atypical multifocal cutaneous leishmaniasis in an immunocompetent patient treated by liposomal amphotericin B.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228299

21 August 2018

Successful treatment of cutaneous leishmaniasis with lipid formulations of amphotericin B in two immunocompromised patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228299

21 August 2018

Topical treatment of persistent cutaneous leishmaniasis with ethanolic lipid amphotericin B.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228299

21 August 2018

Efficacious topical treatment for human cutaneous leishmaniasis with ethanolic lipid amphotericin B.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228299

21 August 2018

A single high dose treatment of kala-azar with Ambisome (amphotericin B lipid complex): a pilot study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228299

21 August 2018

Use of Amphotericin B in Drug-Resistant Cases of Visceral Leishmaniasis in North Bihar, India

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228299

21 August 2018

Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22174993

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel method for the preparation of liposomes: freeze drying of monophase solutions

1 reference

https://pubmed.ncbi.nlm.nih.gov/22174993

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topical amphotericin B for cutaneous leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22174993

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1155/2011/656523

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

release_jfqujyqwajf7riiljnharkwtn4

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39519018&oldid=1833916142"